A. Uccelli, L. Moretta, and V. Pistoia, Mesenchymal stem cells in health and disease, Nature Reviews Immunology, vol.2, issue.9, pp.726-736, 2008.
DOI : 10.1038/nri2395

J. Tan, W. Wu, X. Xu, L. Liao, F. Zheng et al., Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants, JAMA, vol.307, issue.11, pp.1169-1177, 2012.
DOI : 10.1001/jama.2012.316

P. Connick, M. Kolappan, C. Crawley, D. Webber, R. Patani et al., Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study, The Lancet Neurology, vol.11, issue.2, pp.150-156, 2012.
DOI : 10.1016/S1474-4422(11)70305-2

R. Ciccocioppo, M. Bernardo, A. Sgarella, R. Maccario, M. Avanzini et al., Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease, Gut, vol.60, issue.6, pp.788-798, 2011.
DOI : 10.1136/gut.2010.214841

L. Blanc, K. Frassoni, F. Ball, L. Locatelli, F. Roelofs et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, The Lancet, vol.371, issue.9624, pp.1579-1586, 2008.
DOI : 10.1016/S0140-6736(08)60690-X

J. Hare, J. Fishman, G. Gerstenblith, D. F. Velazquez, D. Zambrano et al., Comparison of allogeneic vs autologous bone marrowderived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial, pp.2369-2379, 2012.

L. Sensebe, P. Bourin, and K. Tarte, Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells, Human Gene Therapy, vol.22, issue.1, pp.19-26, 2011.
DOI : 10.1089/hum.2010.197

URL : https://hal.archives-ouvertes.fr/hal-00743942

D. Ugarte, D. , A. Z. Zuk, P. Elbarbary, A. Zhu et al., Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow, Immunology Letters, vol.89, issue.2-3, pp.267-270, 2003.
DOI : 10.1016/S0165-2478(03)00108-1

G. Pachon-pena, G. Yu, A. Tucker, X. Wu, J. Vendrell et al., Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles, Journal of Cellular Physiology, vol.55, issue.33, pp.843-851, 2011.
DOI : 10.1002/jcp.22408

D. Noel, D. Caton, S. Roche, C. Bony, S. Lehmann et al., Cell specific differences between human adipose-derived and mesenchymal???stromal cells despite similar differentiation potentials, Experimental Cell Research, vol.314, issue.7, pp.1575-1584, 2008.
DOI : 10.1016/j.yexcr.2007.12.022

URL : https://hal.archives-ouvertes.fr/hal-00275173

M. Krampera, J. Galipeau, Y. Shi, K. Tarte, and L. Sensebe, Immunological characterization of multipotent mesenchymal stromal cells. The International Society for Cellular Therapy (ISCT) working proposal
URL : https://hal.archives-ouvertes.fr/hal-00866729

G. Ren, J. Su, L. Zhang, X. Zhao, W. Ling et al., Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression, Stem Cells, vol.98, issue.8, pp.1954-1962, 2009.
DOI : 10.1002/stem.118

L. Blanc, K. Mougiakakos, and D. , Multipotent mesenchymal stromal cells and the innate immune system, Nature Reviews Immunology, vol.107, issue.5, pp.383-396, 2012.
DOI : 10.1038/nri3209

G. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. Mingari et al., T.6. Mesenchymal Stem Cells Inhibit Natural Killer Cell Proliferation, Cytotoxicity and Cytokine Production: Role of Indoleamine 2,3-Dioxygenase and Prostaglandin E2, Clinical Immunology, vol.131, pp.1327-1333, 2008.
DOI : 10.1016/j.clim.2009.03.133

I. Prigione, F. Benvenuto, P. Bocca, L. Battistini, A. Uccelli et al., Reciprocal Interactions Between Human Mesenchymal Stem Cells and ???? T Cells Or Invariant Natural Killer T Cells, Stem Cells, vol.9, issue.3, pp.693-702, 2009.
DOI : 10.1634/stemcells.2008-0687

A. Nauta, A. Kruisselbrink, E. Lurvink, R. Willemze, and W. Fibbe, Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.177, issue.4, pp.2080-2087, 2006.
DOI : 10.4049/jimmunol.177.4.2080

F. Guilloton, G. Caron, C. Menard, C. Pangault, P. Ame-thomas et al., Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes, Blood, vol.119, issue.11, pp.2556-2567, 2012.
DOI : 10.1182/blood-2011-08-370908

URL : https://hal.archives-ouvertes.fr/inserm-00665887

M. Francois, R. Romieu-mourez, M. Li, and J. Galipeau, Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation, Molecular Therapy, vol.20, issue.1, pp.187-195, 2012.
DOI : 10.1038/mt.2011.189

J. Kim and P. Hematti, Mesenchymal stem cell???educated macrophages: A novel type of alternatively activated macrophages, Experimental Hematology, vol.37, issue.12, pp.1445-1453, 2009.
DOI : 10.1016/j.exphem.2009.09.004

M. Krampera, Mesenchymal stromal cell ???licensing???: a multistep process, Leukemia, vol.65, issue.9, pp.1408-1414, 2011.
DOI : 10.1038/leu.2011.108

F. Benvenuto, S. Ferrari, E. Gerdoni, F. Gualandi, F. Frassoni et al., Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State, Stem Cells, vol.23, issue.7, pp.1753-1760, 2007.
DOI : 10.1634/stemcells.2007-0068

M. Cassatella, F. Mosna, A. Micheletti, V. Lisi, N. Tamassia et al., Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils, STEM CELLS, vol.52, issue.6, pp.1001-1011, 2011.
DOI : 10.1002/stem.651

M. Hajjami, H. Ame-thomas, P. Pangault, C. Tribut, O. Devos et al., Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase, Cancer Research, vol.69, issue.7, pp.3228-3237, 2009.
DOI : 10.1158/0008-5472.CAN-08-3000

URL : https://hal.archives-ouvertes.fr/inserm-00869384

M. Franquesa, M. Hoogduijn, O. Bestard, and J. Grinyo, Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells, Frontiers in Immunology, vol.3, p.212, 2012.
DOI : 10.3389/fimmu.2012.00212

M. Francois, R. Romieu-mourez, S. Stock-martineau, M. Boivin, J. Bramson et al., Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties, Blood, vol.114, issue.13, pp.2632-2638, 2009.
DOI : 10.1182/blood-2009-02-207795

Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe et al., Regulatory T Cells, Stem Cells, vol.33, issue.1, pp.212-222, 2008.
DOI : 10.1634/stemcells.2007-0554

URL : https://hal.archives-ouvertes.fr/inserm-00483522

H. Choi, R. Lee, N. Bazhanov, J. Oh, and D. Prockop, Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-??B signaling in resident macrophages, Blood, vol.118, issue.2, pp.330-338, 2011.
DOI : 10.1182/blood-2010-12-327353

R. Lee, A. Pulin, M. Seo, D. Kota, J. Ylostalo et al., Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6, Cell Stem Cell, vol.5, issue.1, pp.54-63, 2009.
DOI : 10.1016/j.stem.2009.05.003

J. Oh, G. Roddy, H. Choi, R. Lee, J. Ylostalo et al., Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury, Proceedings of the National Academy of Sciences, vol.107, issue.39, pp.16875-16880, 2010.
DOI : 10.1073/pnas.1012451107

S. Danchuk, J. Ylostalo, F. Hossain, R. Sorge, A. Ramsey et al., Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-??-induced protein 6, Stem Cell Research & Therapy, vol.2, issue.3, p.27, 2011.
DOI : 10.1073/pnas.1008117107

G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang et al., Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide, Cell Stem Cell, vol.2, issue.2, pp.141-150, 2008.
DOI : 10.1016/j.stem.2007.11.014

R. Romieu-mourez, M. Francois, M. Boivin, M. Bouchentouf, D. Spaner et al., Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype, The Journal of Immunology, vol.182, issue.12, pp.7963-7973, 2009.
DOI : 10.4049/jimmunol.0803864

C. Menard, L. Pacelli, G. Bassi, J. Dulong, F. Bifari et al., Clinical-grade mesenchymal stromal cells produced under various GMP processes differ in their immunomodulatory properties: Standardization of immune quality controls, Stem Cells Dev, 2013.

V. Zhukareva, M. Obrocka, J. Houle, I. Fischer, and B. Neuhuber, Secretion profile of human bone marrow stromal cells: Donor variability and response to inflammatory stimuli, Cytokine, vol.50, issue.3, pp.317-321, 2010.
DOI : 10.1016/j.cyto.2010.01.004

L. Sensebe, K. Tarte, J. Galipeau, M. Krampera, I. Martin et al., Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells, Cell Stem Cell, vol.10, issue.1, pp.9-10, 2012.
DOI : 10.1016/j.stem.2011.12.005

URL : https://hal.archives-ouvertes.fr/inserm-00817456

D. Cakouros, S. Isenmann, L. Cooper, A. Zannettino, P. Anderson et al., Twist-1 Induces Ezh2 Recruitment Regulating Histone Methylation along the Ink4A/Arf Locus in Mesenchymal Stem Cells, Molecular and Cellular Biology, vol.32, issue.8, pp.1433-1441, 2012.
DOI : 10.1128/MCB.06315-11

S. Bork, S. Pfister, H. Witt, P. Horn, B. Korn et al., DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells, Aging Cell, vol.58, issue.Suppl, pp.54-63, 2010.
DOI : 10.1111/j.1474-9726.2009.00535.x

J. Coppe, P. Desprez, A. Krtolica, and J. Campisi, The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression, Annual Review of Pathology: Mechanisms of Disease, vol.5, issue.1, pp.99-118, 2010.
DOI : 10.1146/annurev-pathol-121808-102144

L. Von-bahr, B. Sundberg, L. Lonnies, B. Sander, H. Karbach et al., Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy, Biology of Blood and Marrow Transplantation, vol.18, issue.4, pp.557-564, 2012.
DOI : 10.1016/j.bbmt.2011.07.023

J. Galipeau, The mesenchymal stromal cells dilemma -does a negative phase III trial of random donor mesenchymal stromal cells in steroidresistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy, pp.2-8, 2013.

M. Francois, I. Copland, S. Yuan, R. Romieu-mourez, E. Waller et al., Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-?? licensing, Cytotherapy, vol.14, issue.2, pp.147-152, 2012.
DOI : 10.3109/14653249.2011.623691

C. Benezech, E. Mader, G. Desanti, M. Khan, K. Nakamura et al., Lymphotoxin-?? Receptor Signaling through NF-??B2-RelB Pathway Reprograms Adipocyte Precursors as Lymph Node Stromal Cells, Immunity, vol.37, issue.4, pp.721-734, 2012.
DOI : 10.1016/j.immuni.2012.06.010

J. Fujisaki, J. Wu, A. Carlson, L. Silberstein, P. Putheti et al., In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche, Nature, vol.25, issue.7350, pp.216-219, 2011.
DOI : 10.1038/nature10160

C. Shi, T. Jia, S. Mendez-ferrer, T. Hohl, N. Serbina et al., Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands, Immunity, vol.34, issue.4, pp.590-601, 2011.
DOI : 10.1016/j.immuni.2011.02.016

U. Forslow, O. Blennow, K. Leblanc, O. Ringden, B. Gustafsson et al., Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation, European Journal of Haematology, vol.34, issue.3, pp.220-227, 2012.
DOI : 10.1111/j.1600-0609.2012.01824.x

R. Meisel, S. Brockers, K. Heseler, O. Degistirici, H. Bulle et al., Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase, Leukemia, vol.176, issue.4, pp.648-654, 2011.
DOI : 10.1016/j.humimm.2004.02.022

E. Dander, G. Lucchini, P. Vinci, M. Introna, F. Masciocchi et al., Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring, Leukemia, vol.26, issue.7, pp.1681-1684, 2012.
DOI : 10.3960/jslrt.50.79

R. Ciccocioppo, M. Russo, M. Bernardo, F. Biagi, L. Catenacci et al., Mesenchymal Stromal Cell Infusions as Rescue Therapy for Corticosteroid-Refractory Adult Autoimmune Enteropathy, Mayo Clinic Proceedings, vol.87, issue.9, pp.909-914, 2012.
DOI : 10.1016/j.mayocp.2012.04.014